John T. Uchic

Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction

Gondi Kumar, J.C. Dykstra, Ellen Roberts et al. · Drug Metabolism and Disposition · 1999 · 166 citations

Medicine, Pharmacokinetics, Pharmacology +17

Thrombospondin-1 Mimetic Peptide Inhibitors of Angiogenesis and Tumor Growth:  Design, Synthesis, and Optimization of Pharmacokinetics and Biological Activities

Fortuna Haviv, Michael F. Bradley, Douglas Kalvin et al. · Journal of Medicinal Chemistry · 2005 · 138 citations

Pharmacy, Medicinal Chemistry, Pharmacokinetics +14

Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans

Gondi Kumar, Venkata Jayanti, Marianne K. Johnson et al. · Pharmaceutical Research · 2004 · 105 citations

Medicine, Pharmacokinetics, Pharmacology +12

Measurement of Liver Microsomal Cytochrome P450 (CYP2D6) Activity Using [O-methyl-14C] Dextromethorphan

A. David Rodrigues, Michael Kukulka, Bruce W. Surber et al. · Analytical Biochemistry · 1994 · 75 citations

Medicine, Pharmacokinetics, Pharmacology +9

In Vitro Metabolism of the HIV-1 Protease Inhibitor ABT-378: Species Comparison and Metabolite Identification

Gondi Kumar, Venkata Jayanti, Ronald Lee et al. · Drug Metabolism and Disposition · 1999 · 64 citations

Medicine, Biochemistry, Pharmacology +16